Sara has 28 years of experience in Clinical Research in various therapeutic areas, with a strong commitment to serving Oncology patients. She is a proven leader who builds highly respected and very loyal Clinical Operation groups, and in particular at smaller start-up companies. Prior to joining the MBrace team, Sara was the Global Head of Clinical Operations for Clovis Oncology. During her long tenure at Clovis (2010-2023), Sara helped build a team of 3 employees into, at its peak, a group of 65 employees across multiple functions which comprised ClinOps, Translational Medicine Ops, and ClinOps Standards and Innovations to support all phases of the global clinical development programs. Their efforts led to a PARPi (Rucaparib) obtaining approval in the US and Europe with indications in Ovarian and Prostate cancer, in addition to bringing in several new early development compounds. Prior to Clovis, Sara joined Intermune early on and held positions of increasing responsibility across multiple therapeutic areas during her 9 years there. During her career, Sara has been a part of several successful FDA and EMA inspections under global filings with both Agencies. Obtaining her BA in Psychology and Sociology at the University of Colorado at Boulder allowed Sara to ski in very different conditions than her upbringing at a ski resort in Maine and racing in some fairly brutal conditions. Sara had a short stint as a Social Worker and is incredibly satisfied having landed in Clinical Research by happenstance all those years ago.